Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · Real-Time Price · USD

5.58

+0.22 (4.10%)

At close: Apr 28, 2026, 4:00 PM EDT

5.40

-0.18 (-3.23%)

After-hours: Apr 28, 2026, 4:48 PM EDT

Atea Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Atea Pharmaceuticals stock has a target of 10, which predicts an increase of 79.21% from the current stock price of 5.58.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$10	$10	$10
Change	+79.21%	+79.21%	+79.21%	+79.21%

* Price targets were last updated on Mar 9, 2026.

Analyst Ratings

According to 1 stock analyst, the rating for Atea Pharmaceuticals is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	1	1
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Miller Evercore ISI Group	Evercore ISI Group	Buy Maintains $6 → $10	Buy	Maintains	$6 → $10	+79.21%	Mar 9, 2026
Matthew Harrison Morgan Stanley	Morgan Stanley	Hold Maintains $6.2 → $6	Hold	Maintains	$6.2 → $6	+7.53%	Apr 11, 2025
Matthew Harrison Morgan Stanley	Morgan Stanley	Sell → Hold Upgrades $2 → $6.88	Sell → Hold	Upgrades	$2 → $6.88	+23.30%	Aug 13, 2024
Eric Joseph JP Morgan	JP Morgan	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Aug 10, 2023
Eric Joseph JP Morgan	JP Morgan	Hold Maintains $12 → $8	Hold	Maintains	$12 → $8	+43.37%	Mar 16, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

31.07M

EPS This Year

-1.69

from -1.94

EPS Next Year

-1.69

from -1.69

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	351.37M	-	-	-	-	-	31.07M
Revenue Growth	622.49%	-	-	-	-	-	-
EPS	1.37	-1.39	-1.63	-2.00	-1.94	-1.69	-1.69
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	64.0M
Avg	n/a	31.1M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.74	-1.74
Avg	-1.69	-1.69
Low	-1.63	-1.63

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.